CAS: 942918-07-2 - N'-[4-[4-[2-[3-[(Dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethylurea
Formula:C30H33N7O
InChI:InChI=1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38)
- Synonyms:
- 3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea
- Gsk-1070916A
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
GSK-1070916 REF: IN-DA019FTVCAS: 942918-07-2 | 99% | To inquire | Tue 07 Jan 25 | |
GSK-1070916 REF: TM-T6129CAS: 942918-07-2 | 98.51% | 48.00 €~604.00 € | Tue 07 Jan 25 | |
GSK 1070916 REF: 3D-FD153251CAS: 942918-07-2 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA019FTV
1mg | 72.00 € | ||
5mg | 144.00 € | ||
10mg | 154.00 € | ||
25mg | 304.00 € | ||
50mg | 604.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
GSK-1070916
CAS:942918-07-2
GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 …
Formula:
C30H33N7O
Purity:
98.51%
Color and Shape:
Solid
Molecular weight:
507.63
- Inhibitors
- Apoptosis
- Cell Cycle/Checkpoint
- Chromatin/Epigenetics
- See more categories
- Aurora Kinase
Ref: TM-T6129
1mg | 48.00 € | ||
5mg | 93.00 € | ||
10mg | 156.00 € | ||
25mg | 259.00 € | ||
50mg | 406.00 € | ||
100mg | 604.00 € | ||
1mL*10mM (DMSO) | 106.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
GSK 1070916
CAS:942918-07-2
Potent and ATP-competitive inhibitor of Aurora kinase B and C
Formula:
C30H33N7O
Purity:
Min. 95%
Color and Shape:
Solid
Molecular weight:
507.63 g/mol
Ref: 3D-FD153251
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025